Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis
Clinical trial NCT06183242 · COMPLETED
Trial details
- NCT number
- NCT06183242
- Sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-27
- Primary completion
- 2024-09-24
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.